Vous avez cherché: weight (Maltais - Anglais)

it-tunellaġġ dead-weight,
dead-weight tonnage,

proporzjon piż/utilità (weight/utility ratio, wur)
weight/utility ratio (wur)

age (years) weight (kg) serum creatinine for female patients
serum creatinine (μmol/l)

however, all physical activity increases energy consumption and contributes to weight managementlii.
however, all physical activity increases energy consumption and contributes to weight management52.

animal body weight, food/water intake, dose formulation and administration, etc.;
le poids corporel des animaux, les quantités d'eau et d'aliments ingérées, la préparation et l'administration des doses, etc.,

109.l-evalwazzjoniex-postta’leader+li għaddejjaqiegħdatindirizzad-dead-weight.
109.theongoingex-postevaluationof leader+isaddressingdeadweight.

standard test method for molecular weight averages and molecular weight distribution of polystyrene by high performance size-exclusion chromatography.
standard test method for molecular weight averages and molecular weight distribution of polystyrene by high performance size-exclusion chromatography.

standard test method for molecular weight averages and molecular weight distribution by liquid exclusion chromatography (gel permeation chromatography-gpc).
standard test method for molecular weight averages and molecular weight distribution by liquid exclusion chromatography (gel permeation chromatography-gpc).

the weight of elephants ta’ daniel josh borgman (in-new zealand/id-danimarka, forum)
the weight of elephants by daniel josh borgman (new zealand/denmark, forum)

billi t- tneħħija ta 'pregabalin hija direttament proporzjonali mat- tneħħija tal - kreatinina (ara sezzjoni 5. 2), it- tnaqqis fid- doża f' pazjenti b' funzjoni renali kompromessa jrid ikun individwalizzat skond it- tneħħija tal- kreatinina (clcr), kif indikat f' tabella 1 stabbilit billi tintuża l - formula li ġejja: ⎡1. 23 × [140 - age (years)] x weight (kg) ⎤ ⎥ (x 0. 85 for female patients) clcr( ml/ min) = ⎢ ⎥
as pregabalin clearance is directly proportional to creatinine clearance (see section 5.2), dosage reduction in patients with compromised renal function must be individualised according to creatinine clearance (clcr), as indicated in table 1 determined using the following formula: